We’re honoured to announce that Upperton has been recognised as one of the Sunday Times’ 100 fastest-growing companies in the UK for 2024.
The Sunday Times 100 list ranks private companies with the fastest business growth over the past three years. The league table takes on the baton from The Sunday Times Fast Track 100 series, which celebrated the country’s leading entrepreneurs for 24 years.
Our placement at number #73 is a remarkable indicator of our growth trajectory and our crucial role in developing and manufacturing high-quality drug products.
In the past three years, we have seen tremendous expansion in our team, drawing top talent from local universities and across the Midlands. A significant milestone in our journey was the design, construction, and validation of a new 50,000 sq ft development and manufacturing facility in Nottingham within just 10 months, a feat that is unmatched in our industry.
Being recognised in the Sunday Times 100 not only highlights our rapid growth but also underscores our value as a leading Contract Development and Manufacturing Organisation (CDMO).
Nikki Whitfield, our CEO, shared her thoughts: “At Upperton, we are dedicated to providing the highest service, both now and in the future. Being featured in the 2024 edition of The Sunday Times 100 is a significant professional endorsement, and we are incredibly proud of this achievement. This milestone is a testament to the hard work and dedication of our amazing team, who consistently deliver outstanding service to our clients.”
We are thrilled to be included in this prestigious list and are even more excited about Upperton’s future. We continue to advance the construction of our new sterile GMP facility, further expanding our capabilities and service offering, enabling further growth and innovation over the coming years.
Interested in joining our rapidly growing CDMO? Explore our current job openings here, or learn more by downloading our corporate brochure below.
